Who
Paul Thomas
Director
Company insider
Files Form 4 as: Director, Axogen; Director, TELA Bio; Director, Abiomed; Director, Surgalign Holdings; Director, Rti Surgical; Director, Aegerion Pharmaceuticals; President and CEO, Roka BioScience; Director, Orthovita.
In numbers
- Trades disclosed
- 202
- Buys
- 0
- Sells
- 15
- Bought
- $0
- Sold
- $15.3M
- Companies
- 11
- Companies where not an officer
- 8
- First trade
- 3 Jan 2006
- Last trade
- 24 Jun 2026
- Last filed
- 26 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Jun 2026filed 26 Jun 2026 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code A | —5,579 at $0.00 | filing |
| 24 Jun 2026filed 26 Jun 2026 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code A | —5,579 at $0.00 | filing |
| 19 Jun 2026filed 23 Jun 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code M | —18,867 at $0.00 | filing |
| 19 Jun 2026filed 23 Jun 2026 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code M | —18,867 at $0.00 | filing |
| 19 Jun 2026filed 23 Jun 2026 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code M | —18,867 at $0.00 | filing |
| 19 Jun 2026filed 23 Jun 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code M | —18,867 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Code A | —11,925 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Code A | —11,675 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | TELA TELA Biooption or derivative · Medical Devices | SEC FORM 4 Code A | —17,550 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | TELA TELA Biooption or derivative · Medical Devices | SEC FORM 4 Code A | —17,550 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | TELA TELA Biooption or derivative · Medical Devices | SEC FORM 4 Code A | —17,335 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | TELA TELA Biooption or derivative · Medical Devices | SEC FORM 4 Code A | —17,335 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Code A | —11,925 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Code A | —11,675 at $0.00 | filing |
| 9 Dec 2025filed 10 Dec 2025 | AXGN AxogenMedical Devices | SEC FORM 4 Sold | $634K21,399 at $29.61 | filing |
| 19 Jun 2025filed 20 Jun 2025 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code A | —18,867 at $0.00 | filing |
| 16 Sep 2024filed 17 Sep 2024 | AXGN AxogenMedical Devices | SEC FORM 4 Code A | —2,875 | filing |
| 1 Sep 2024filed 4 Sep 2024 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code M | —11,904 at $0.00 | filing |
| 1 Sep 2024filed 4 Sep 2024 | AXGN AxogenMedical Devices | SEC FORM 4 Code M | —11,904 at $0.00 | filing |
| 6 Jun 2024filed 10 Jun 2024 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code A | —18,248 at $0.00 | filing |
News
Cameron Winter and Paul Thomas Anderson Interview, BTSvulture.com · 1 Oct 2026Former Gibson County Sheriff Paul Thomas Back in Court; Defense Seeks Case Consolidation and Dismissalwbbjtv.com · 22 Sep 2026One Of Paul Thomas Anderson's Best Movies Is Always Overshadowed, Despite Starring A Legendcinemablend.com · 20 Sep 2026Naomi Watts Says She'd Like To Work With Paul Thomas Andersondeadline.com · 19 Sep 2026London Film Festival Adds Paul Thomas Anderson's Cameron Winter Filmdeadline.com · 7 Sep 2026Analyzing AxoGen (NASDAQ:AXGN) & AtriCure (NASDAQ:ATRC)AXGN · tickerreport.com · 18 Oct 2026
5 headlines in the last 90 days name Paul Thomas; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.